The role of transferrin receptors in crossing the blood-brain barrier in the treatment of mucopolysaccharidosis

Background. Currently, in Russia, intravenous enzyme replacement therapy is used for the treatment of mucopolysaccharidosis type II. In recent months, enzyme replacement therapy administered via the cerebral ventricles (intracerebroventricular administration) has become available. The main drawback...

全面介紹

書目詳細資料

Principais autores:	Larisa I. Minaycheva, Gulnara N. Seitova, Ekaterina A. Shatokhina
格式:	Artigo
語言:	Russo
出版:	Open Systems Publication 2026-04-01
叢編:	Лечащий Врач
主題:	мукополисахаридоз ii типа лизосомные болезни накопления рецепторы трансферрина гематоэнцефалический барьер
在線閱讀:	https://journal.lvrach.ru/jour/article/view/1592
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!